Apolipoprotein E drives primary resistance to androgen receptor (AR)-targeted therapy by fostering tripartite motif containing 25 (TRIM25)-mediated androgen receptor (AR) ubiquitination, and enhances immunotherapy efficacy in PCa (29). This evidence concerns the gene AR and posterior cortical atrophy.